Friday, December 20, 2019

Lupin gets USFDA nod to market skin ointment

Lupin gets USFDA nod to market skin ointment The approval by the United States Food and Drug Administration (USFDA) is to market its generic Betamethasone Dipropionate ointment USP (augmented), 0.05 per cent, it added.

from Moneycontrol Business News https://ift.tt/2txbO5e

No comments:

Post a Comment

KPI Green Energy Q4 cons PAT jumps 46% YoY to Rs 155 cr; revenue up 40%

KPI Green Energy Q4 Results: KPI Green Energy announced strong financial results for the fourth quarter of FY26. Net profit surged by 46% t...